# A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.

> **NCT06363773** · NA · RECRUITING · sponsor: **Elsan** · enrollment: 35 (estimated)

## Conditions studied

- Metastatic Cancer

## Interventions

- **RADIATION:** Stereotactic Radiotherapy

## Key facts

- **NCT ID:** NCT06363773
- **Lead sponsor:** Elsan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-27
- **Primary completion:** 2027-04
- **Final completion:** 2028-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06363773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06363773, "A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06363773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*